Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HEMONTO A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8%   Bankruptcy risk   1.1% 1.3% 0.9% 0.7% 0.7% 1.1% 14.7% 12.8%   Credit score (0-100)   86 82 89 93 94 83 13 18   Credit rating   A A A AA AA A BB BB   Credit limit (kDKK)   789.8 177.2 822.0 1,603.9 2,898.8 244.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   16,166 19,856 20,867 22,238 26,126 17,958 0.0 0.0   EBITDA   4,794 4,857 2,503 5,184 5,016 526 0.0 0.0   EBIT   4,193 4,138 2,106 4,818 4,561 526 0.0 0.0   Pre-tax profit (PTP)   4,166.6 4,082.7 2,060.5 4,812.2 4,602.6 654.5 0.0 0.0   Net earnings   3,189.1 3,177.8 1,604.4 4,148.4 4,139.9 436.3 0.0 0.0   Pre-tax profit without non-rec. items   4,167 4,083 2,060 4,812 4,603 655 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   268 7.2 4.1 17.0 16.0 442 0.0 0.0   Shareholders equity total   7,700 2,577 4,182 8,330 12,470 2,936 436 436   Interest-bearing liabilities   0.0 0.0 0.0 0.0 20,005 8,857 0.0 0.0   Balance sheet total (assets)   11,316 6,317 8,207 17,557 49,057 17,602 436 436   Net Debt   -9,181 -3,714 -6,147 -5,889 -3,087 7,055 -436 -436     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   16,166 19,856 20,867 22,238 26,126 17,958 0.0 0.0   Gross profit growth   12.7% 22.8% 5.1% 6.6% 17.5% -31.3% -100.0% 0.0%   Employees   18 24 38 35 41 26 0 0   Employee growth %   -5.3% 33.3% 58.3% -7.9% 17.1% -36.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   11,316 6,317 8,207 17,557 49,057 17,602 436 436   Balance sheet change%   13.2% -44.2% 29.9% 113.9% 179.4% -64.1% -97.5% 0.0%   Added value   4,192.9 4,138.0 2,106.4 4,817.9 4,561.1 526.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -989 -945 -792 -603 18,022 -18,055 -442 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   25.9% 20.8% 10.1% 21.7% 17.5% 2.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   39.3% 46.9% 29.0% 37.8% 14.1% 2.1% 0.0% 0.0%   ROI %   55.0% 78.3% 56.0% 63.4% 20.5% 2.9% 0.0% 0.0%   ROE %   42.9% 61.8% 47.5% 66.3% 39.8% 5.7% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   68.0% 40.8% 51.0% 50.5% 25.4% 16.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -191.5% -76.5% -245.6% -113.6% -61.5% 1,340.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 160.4% 301.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.8% 0.2% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   2.9 1.4 2.1 1.8 0.9 1.2 0.0 0.0   Current Ratio   2.9 1.4 2.1 1.6 0.9 1.2 0.0 0.0   Cash and cash equivalent   9,180.7 3,714.2 6,146.8 5,888.6 23,091.5 1,802.1 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   6,469.8 1,563.6 3,876.1 3,874.1 -3,974.2 2,681.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   233 172 55 138 111 20 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   266 202 66 148 122 20 0 0   EBIT / employee   233 172 55 138 111 20 0 0   Net earnings / employee   177 132 42 119 101 17 0 0